Skip to main content
. 1998 Oct 5;188(7):1359–1368. doi: 10.1084/jem.188.7.1359

Table 1.

Receptor Profile of Various APCs

Immature DCs Day 7 Mature DCs Day 11 Monocytes Day 0 Macrophages Day 3 Macrophages Day 9
n = 7 n = 6 n = 4 n = 5 n = 5
CD8* 0–2 (3 ± 1)§ 0–3 (4 ± 1) 0–1 (4 ± 1) 0–5 (3 ± 1) 1–2 (3 ± 1)
CD14* 1–10 (4 ± 1) 0–6 (4 ± 1) 83–97 (149 ± 90) 67–98 (61 ± 20) 49–90 (68 ± 48)
CD83 8–43 (8 ± 4) 73–99 (114 ± 15) 0–1 (3 ± 1) 4–19 (4 ± 2) 2–14 (4 ± 2)
MHC I 99–100 (311 ± 49) 96–100 (280 ± 69) 99–100 (99 ± 38) 97–99 (164 ± 24) 95–100 (116 ± 18)
HLA-DR* 88–100 (84 ± 35) 98–99 (188 ± 40) 94–99 (63 ± 9) 97–99 (173 ± 34) 5–89 (25 ± 27)
CD8 3–9 (4 ± 1) 2–8 (3 ± 1) 0–2 (3 ± 1) 1–4 (3 ± 0) 1–5 (3 ± 1)
IgG2b 3–7 (3 ± 1) 2–7 (3 ± 1) 0–2 (3 ± 0) 1–4 (3 ± 1) 1–5 (3 ± 1)
CD36 75–99 (75 ± 31) 20–50 (9 ± 2) 89–99 (62 ± 18) 64–98 (69 ± 45) 9–55 (15 ± 16)
αv (CD51) 45–76 (14 ± 3) 11–40 (9 ± 3) 2–12 (4 ± 1) 2–35 (6 ± 2) 18–75 (10 ± 5)
β1 (CD29) 99–100 (287 ± 57) 84–100 (112 ± 28) 95–100 (61 ± 33) 83–100 (72 ± 23) 68–99 (104 ± 29)
β3 (CD61) 14–34 (7 ± 2) 10–24 (6 ± 1) 76–91 (40 ± 16) 15–85 (14 ± 9) 19–92 (16 ± 9)
β5 78–95 (30 ± 8) 32–57 (11 ± 2) 6–8 (5 ± 1) 8–15 (7 ± 2) 5–8 (3 ± 1)
αvβ3 (VnR) 22–28 (7 ± 1) 14–30 (7 ± 2) 4–8 (4 ± 1) 7–27 (5 ± 2) 19–68 (10 ± 4)
αvβ5 81–90 (25 ± 5) 12–53 (9 ± 3) 1–14 (4 ± 1) 0–11 (3 ± 1) 6–15 (4 ± 1)
CD71 75–99 (50 ± 29) 75–94 (61 ± 27) 3–7 (4 ± 0) 14–30 (7 ± 2) 58–81 (30 ± 7)
Mannose receptor 99–100 (272 ± 68) 38–80 (26 ± 11) 2–7 (4 ± 0) 24–63 (13 ± 8) 48–95 (34 ± 20)
*

PE-conjugated.  

Unconjugated antibody.  

§

Results are expressed as range of values, calculated as percentage of positive cells as compared with an isotype-matched control antibody. Values in parentheses indicate the average of geometric mean fluorescence intensities of the various samples ± SD.  

The β3 expression in the monocytes and day 3 macrophages does not match the αvβ3 expression due to contaminating platelets that stuck to the cells during isolation, as determined by staining with anti-CD41 (data not shown).